entertainment -WSS

entertainment

author：fashion 2025-10-01 00:59:10 - browse：799

Photo illustration of Stephen HEMSLEY -- UnitedHealth coverage from STAT — Stephen Hemsley, chair of the board and former chief executive officer of UnitedHealth Group Inc. Photo illustration: Alex Hogan; Source: AP

Stephen Hemsley, the former CEO of UnitedHealth Group and its current board chair, also owns an investment firm that manages his own portfolio of UnitedHealth stock and oversees other wealthy individuals’ accounts that have held shares of companies that have direct business with or indirect ties to United.

It’s an unusual arrangement for someone in such a prominent role at one of the largest health care corporations in the world, according to several experts in securities and corporate law interviewed by STAT, and one that they said highlights shortcomings in government disclosure requirements and raises concerns about potential conflicts of interest.

The arrangement is perfectly legal. But while other board chairs at large publicly traded health care companies, like Thomas Frist III at HCA Healthcare, hold high-ranking titles in the investment world, none were longtime chief executives of the same company they chair, like Hemsley. UnitedHealth also does not disclose Hemsley’s investment firm ownership to its shareholders in regular disclosures.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Medicare threatens to cut off funding for HCA's Mission hospital

WSS

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Medicare threatens to cut off funding for HCA's Mission hospital

How neuroscience research could help beat back brain cancer

Medicare must police algorithms in Medicare Advantage, Dems say

Humans aren't the only ones with an imagination. Rats have it too

Prime Medicine says its gene editing passes test in monkeys

hotspot

entertainment

Wikipedia

Medicare proposal to cover medical devices draws a mixed reaction

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Medical leaders decry Supreme Court decision on affirmative action

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How digital tools helped lower hypertension in marginalized patients

Medical leaders decry Supreme Court decision on affirmative action

The health care issue Democrats can’t solve: hospital reform

State Dept. review finds Biden bears some blame for Afghanistan failures

Biden report: The neurospychology of memory and aging

Wikipedia

Private equity deals in Medicare Advantage declines

Biogen Alzheimer’s drug launch off to slow start

Medicare must police algorithms in Medicare Advantage, Dems say

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

How neuroscience research could help beat back brain cancer

DeepMind touts AlphaFold's new skills as protein folding AI models face off

entertainment

leisure time

Wikipedia

focus